Goodrich Katherine bought TARS
June 25, 2026 · Form 4 insider transaction
Goodrich Katherine bought 3,837 shares of Tarsus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,837
Price
$0.00
Total value
N/A
InsiderGoodrich Katherine
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 25, 2026
Filing dateJune 29, 2026
Shares owned after3,837
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.